OrthoPediatrics Corp. / Fundamentals
Income statement
- Net revenue
€190.17M - Cost of goods sold
€54.13M - Gross profit
€136.04M - SG&A expenses
€155.65M - R&D expenses
€8.62M - EBITDA
-€28.58M - D&A
€12.44M - EBIT
-€28.22M - Interest expenses
€3.42M - EBT
-€37.11M - Tax expenses
-€1.13M - Net income
-€35.98M
Cash flow statement
- Net deferred tax
-€1.32M - Non-cash items
-€18.01M - Changes in working capital
€1.29M - Operating cash flow
-€24.88M - Capex
€7.57M - Other investing cash flow
-€44.69M - Net investing cash flow
-€33.35M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€73.68M - Other financing cash flow
-€3.70M - Net financing cash flow
€71.21M - Foreign exchange effects
€568.62K - Net change in cash
€13.54M - Cash at end of period
€40.15M - Free cash flow
-€17.31M
Balance sheet
- Cash and cash equivalents
€38.38M - Cash and short-term investments
€60.44M - Total receivables
€46.35M - Inventory
€107.92M - Other current assets
€7.32M - Total current assets
€222.02M - Property, plant & equipment
€45.60M - Goodwill
€85.31M - Intangible assets
€68.95M - Long-term investments
€0.00 - Other non-current assets
€12.00M - Total non-current assets
€211.86M - Total assets
€433.88M - Accounts payable
€10.93M - Short-term debt
€141.29K - Other current liabilities
€22.24M - Total current liabilities
€33.31M - Long-term debt
€83.57M - Deferred tax liabilities
€3.04M - Other non-current liabilities
€7.67M - Total non-current liabilities
€94.28M - Total liabilities
€127.59M - Common stock
€5.17K - Retained earnings
-€218.26M - Other equity
-€4.26M - Total equity
€306.29M - Total liabilities and shareholders' equity
€433.88M
Company information
- Market capitalization
€451.48M - Employees
562 - Enterprise Value
€538.13M
Company ratios
- Gross margin
-
71.5% Even with peer group: 67.0% - EBITDA margin
-
-15.0% Worse than peer group: -7.1% - EBIT margin
-
-14.8% Even with peer group: -12.2% - EBT margin
-
-19.5% Even with peer group: -15.5% - Net margin
-
-18.9% Even with peer group: -17.3% - ROE
-
-11.7% Better than peer group: -19.4% - ROA
-
-8.3% Even with peer group: -6.5% - Asset turnover
-
43.8% Much worse than peer group: 71.1% - FCF margin
-
-17.1% Even with peer group: -12.6% - FCF yield
-7.2% - Efficiency ratio
115.0% - Net sales per employee
-
€338.38K - Net income per employee
-
-€64.02K